XENOPORT INC
DelistedCIK 1130591fmd_0RFTAGQCX1956CCKPFECQ37M0HManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2008 to Mar 31, 2016, 29 periods
| Line item | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | 42 | 34 | 3 | 44 | 22 | 8 | 47 | 41 |
| Cost of revenue | – | – | – | – | – | 1 | 2 | 2 |
| Gross profit | – | – | – | – | – | 7 | 45 | 39 |
| Research and development | 83 | 71 | 53 | 44 | 43 | 33 | 24 | 23 |
| Selling, general and administrative | 26 | 32 | 28 | 30 | 30 | 59 | 70 | 95 |
| Total operating expenses | 110 | 103 | 86 | 77 | 53 | 94 | – | – |
| Operating income | (68) | (68) | (83) | (34) | (31) | (86) | (49) | (79) |
| Interest expense | 0 | 0 | – | – | – | 0 | 0 | 4 |
| Interest and investment income | – | – | – | 0 | 0 | 0 | 0 | 1 |
| Income before taxes | (63) | (67) | (82) | (33) | – | – | – | – |
| Income tax expense | (0) | (1) | – | – | – | – | – | – |
| Net income from continuing operations | (63) | (66) | – | – | – | – | – | – |
| Net income | (63) | (66) | (82) | (33) | (31) | (86) | (49) | (82) |